{"DataElement":{"publicId":"5227998","version":"1","preferredName":"Conceptual Parent Tissue Biospecimen Gross Appearance Type","preferredDefinition":"The gross appearance of the parent sample as determined in the pathology gross room.","longName":"PARENT_GRS_APRNC_TYP","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"5227307","version":"1","preferredName":"Conceptual Parent Tissue Biospecimen Gross Appearance","preferredDefinition":"Something from which one or more similar and separate things have developed, or to which they are attached._An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function._Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._The outward or visible aspect of a person or thing._Visible to the naked eye.","longName":"5202038v1.0:5226918v1.0","context":"BBRB","contextVersion":"1","ObjectClass":{"publicId":"5202038","version":"1","preferredName":"Conceptual Parent Tissue Biospecimen","preferredDefinition":"Something from which one or more similar and separate things have developed, or to which they are attached.:An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.:Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","longName":"C80013:C12801:C70699","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Conceptual Parent","conceptCode":"C80013","definition":"Something from which one or more similar and separate things have developed, or to which they are attached.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Biospecimen","conceptCode":"C70699","definition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2ED82A9C-9E13-7E45-E050-BB89AD432080","latestVersionIndicator":"Yes","beginDate":"2016-03-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-03-24","modifiedBy":"ONEDATA","dateModified":"2016-03-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5226918","version":"1","preferredName":"Gross Appearance","preferredDefinition":"Visible to the naked eye.:The outward or visible aspect of a person or thing.","longName":"C43566:C25377","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gross","conceptCode":"C43566","definition":"Visible to the naked eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Appearance","conceptCode":"C25377","definition":"The outward or visible aspect of a person or thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3089D710-74D4-3EB2-E050-BB89AD430723","latestVersionIndicator":"Yes","beginDate":"2016-04-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-15","modifiedBy":"ONEDATA","dateModified":"2016-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2230266","version":"1","preferredName":"Tissue Banking","preferredDefinition":"Concepts linked to Tissue Banking and Pathology activities","longName":"TISSUE BANKING","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F78BDEC8-6723-436F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-20","modifiedBy":"REEVESD","dateModified":"2005-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30CDD4EF-1851-3727-E050-BB89AD430B4A","latestVersionIndicator":"Yes","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"HARTLEYG","dateModified":"2016-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5227231","version":"1","preferredName":"Gross Appearance Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"5227231v1.0","context":"BBRB","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other, specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30CDD4EF-1880-3727-E050-BB89AD430B4A","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"ONEDATA","dateModified":"2016-04-18","deletedIndicator":"No"},{"value":"Tumor Edge","valueDescription":"Neoplasm Margin","ValueMeaning":{"publicId":"5227232","version":"1","preferredName":"Neoplasm Margin","longName":"5227232","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: A boundary line or the area immediately inside the boundary.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Margin","conceptCode":"C25563","definition":"A boundary line or the area immediately inside the boundary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30CC0AAE-19DD-8EE5-E050-BB89AD433C11","latestVersionIndicator":"Yes","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30CDD4EF-1894-3727-E050-BB89AD430B4A","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"ONEDATA","dateModified":"2016-04-18","deletedIndicator":"No"},{"value":"Tumor Center","valueDescription":"Neoplasm Center","ValueMeaning":{"publicId":"5227233","version":"1","preferredName":"Neoplasm Center","longName":"5227233","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: A point or area that is approximately central within some larger region or structure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Center","conceptCode":"C25445","definition":"A point or area that is approximately central within some larger region or structure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30CC0AAE-1A03-8EE5-E050-BB89AD433C11","latestVersionIndicator":"Yes","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30CC0AAE-1A1C-8EE5-E050-BB89AD433C11","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"ONEDATA","dateModified":"2016-04-18","deletedIndicator":"No"},{"value":"Tumor","valueDescription":"Neoplasm","ValueMeaning":{"publicId":"3071117","version":"1","preferredName":"Neoplasm","longName":"3071117","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"84B019E9-7DC7-77A7-E040-BB89AD4330E0","latestVersionIndicator":"Yes","beginDate":"2010-04-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30CC0AAE-1A26-8EE5-E050-BB89AD433C11","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"ONEDATA","dateModified":"2016-04-18","deletedIndicator":"No"},{"value":"Metastatic","valueDescription":"Metastatic","ValueMeaning":{"publicId":"3438544","version":"1","preferredName":"Metastatic","longName":"3438544","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BDF7A8D0-B86E-5F0A-E040-BB89AD434D34","latestVersionIndicator":"Yes","beginDate":"2012-04-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"30CC0AAE-1A30-8EE5-E050-BB89AD433C11","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"ONEDATA","dateModified":"2016-04-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30CC0AAE-19C7-8EE5-E050-BB89AD433C11","latestVersionIndicator":"Yes","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"HARTLEYG","dateModified":"2016-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736431","version":"1","longName":"Tissue Receipt - Dissection","context":"BBRB"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"Gross appearance of parent ti","type":"Preferred Question Text","description":"Gross appearance of parent tissue specimen as determined in pathology gross room","url":null,"context":"BBRB"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"30E64D59-54A6-D7DB-E050-BB89AD430D4B","latestVersionIndicator":"Yes","beginDate":"2016-04-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-20","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}